Enanta Pharmaceuticals, Inc. (ENTA)
13.54
-0.20
(-1.46%)
USD |
NASDAQ |
Mar 06, 16:00
13.53
-0.01
(-0.07%)
After-Hours: 20:00
Enanta Pharmaceuticals Cash from Investing (TTM) : -75.85M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Agios Pharmaceuticals, Inc. | 377.18M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |
| Savara, Inc. | 93.02M |
| BioMarin Pharmaceutical, Inc. | -414.24M |